![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Ovarian Hyperstimulation Syndrome - 25 Studies Found
Not yet recruiting |
: Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome : Ovarian Hyperstimulation Syndrome : 2016-07-14 :
|
Completed |
: Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome : Ovarian Hyperstimulation Syndrome : 2009-11-13 :
|
Completed |
: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors : Ovarian Hyperstimulation Syndrome : 2009-03-21 : Drug: Cetrotide acetate cetrotide acetate is a GnRH antagonist. The dose is 3 mg once on the day of oocy |
Withdrawn |
: The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome : Ovarian Hyperstimulation Syndrome : 2008-02-05 :
|
Withdrawn |
: Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) : Ovarian Hyperstimulation Syndrome : 2015-03-13 :
|
Active, not recruiting |
: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers : Ovarian Hyperstimulation Syndrome : 2012-02-15 :
|
Completed |
: Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome : Ovarian Hyperstimulation Syndrome : 2008-04-18 : Drug: Quinagolide • Quinagolide 200 μg/day (dos |
Completed |
: Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. : Ovarian Hyperstimulation Syndrome (OHSS) : 2012-10-03 : Other: Highly purified menotropin (HP- hMG) treatment No intervention: patients treated by highly purifi |
Recruiting |
: The Influence of Timing of Cabergoline Initiation on Prevention of OHSS : Ovarian Hyperstimulation Syndrome : 2015-11-24 :
|
Completed |
: Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist : Ovarian Hyperstimulation Syndrome : 2009-02-02 |